Pharmaceutical Products

Share us

842133-18-0;Canagliflozin;JNJ 24831754ZAE; JNJ 284

842133-18-0;Canagliflozin;JNJ 24831754ZAE; JNJ

Description

Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine.
http://www.chemscene.com/Canagliflozin.html

842133-18-0, Canagliflozin;JNJ 24831754ZAE; JNJ 284,

Read More

Previous

1030377-33-3;MK-4305;Suvorexant; MK 4305...

Previous

603139-19-1;Odanacatib;MK-0822;MK 0822;MK0822...

ChemScene, LLC

ChemScene Pharmaceutical chemical

Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097

Tel: 732-484-9848
Fax:

H5响应式定制设计
26种语言,SEO营销型网站


H5/响应式/营销型企业网站; 26种语言扩展;
覆盖: 英文、法语、德语、西班牙语、葡萄牙语、俄语、阿拉伯语、波斯语、日语、韩语
了解更多